Eckartsberga, Germany

Andreas Stallmach

USPTO Granted Patents = 2 

 

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2018-2019

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations by Andreas Stallmach

Introduction

Andreas Stallmach is a notable inventor based in Eckartsberga, Germany. He has made significant contributions to the field of medical materials, particularly in the development of glass elements that are beneficial for human and animal health. With a total of 2 patents, Stallmach's work focuses on creating materials that are less susceptible to biofilm formation.

Latest Patents

Stallmach's latest patents include a medical glass element designed to be less populated by biofilms than existing materials. This innovative material is well tolerated by the body and can be introduced or attached to a human or animal body. The composition of the glass and/or glass ceramic material includes SiO in a range from 60 to 75 wt % and ZnO in a range from 1 to 7 wt %. This unique formulation inhibits biofilm formation and promotes the growth of human or animal cells when the element is integrated into the body.

Career Highlights

Andreas Stallmach is associated with Schott AG, a company renowned for its expertise in glass and glass-ceramic materials. His work at Schott AG has allowed him to focus on innovative solutions that address critical challenges in medical applications. His contributions have been instrumental in advancing the field of biocompatible materials.

Collaborations

Stallmach collaborates with talented individuals such as Sabine Pichler-Wilhelm and Oliwia Makarewicz. Their combined efforts contribute to the development of cutting-edge technologies in the medical field.

Conclusion

Andreas Stallmach's innovative work in medical glass elements showcases his commitment to improving health outcomes through advanced materials. His patents reflect a significant step forward in the fight against biofilm-related complications in medical applications.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…